What we learned GLP-1 use was historically limited in OSA treatment
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin in type 2 diabetes mellitus (LEAD-2 Met)
& Mingrone, G
US Food and Drug Administration (FDA) Approvals of GLP-1 and GLP1 /GIP RAs 11,22-34 However, these labels are being expanded to include additional indications for patients with a spectrum of other cardiometabolic conditions, such as obesity, cardiovascular disease, chronic kidney disease, and obstructive sleep apnea
No countdown timers, no urgency messaging, no forced prompts
Learn about both injectable and oral GLP-1 options to choose what suits your needs